These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3531086)

  • 1. Inhibition of immune-mediated low-dose streptozotocin diabetes by agents which reduce vascular permeability.
    Schwab E; Burkart V; Freytag G; Kiesel U; Kolb H
    Immunopharmacology; 1986 Aug; 12(1):17-21. PubMed ID: 3531086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetogenic action of streptozotocin: essential role of membrane permeability.
    Beppu H; Maruta K; Kürner T; Kolb H
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):90-5. PubMed ID: 2949474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse.
    Jansson L; Sandler S
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):225-30. PubMed ID: 3124343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloxan-induced diabetes in the mouse: time course of pancreatic B-cell destruction as reflected in an increased islet vascular permeability.
    Jansson L; Sandler S
    Virchows Arch A Pathol Anat Histopathol; 1986; 410(1):17-21. PubMed ID: 3097948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of aloe carboxypeptidase fraction on streptozotocin-induced enhancement of vascular permeability in the pancreatic islets.
    Beppu H; Shimpo K; Chihara T; Tamai I; Nomoto-Yamaji S; Ozaki S; Ito S; Kuzuya H
    Phytomedicine; 2006 Jan; 13(1-2):49-60. PubMed ID: 16360933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular permeability of pancreatic islets after administration of streptozotocin.
    Sandler S; Jansson L
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):359-67. PubMed ID: 2413613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of pancreatic beta cells in response to long-term normoglycemia after pancreas or islet transplantation in severely streptozotocin diabetic adult rats.
    Jörns A; Klempnauer J; Tiedge M; Lenzen S
    Pancreas; 2001 Aug; 23(2):186-96. PubMed ID: 11484921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
    Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
    Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice.
    Rosenberg L; Lipsett M; Yoon JW; Prentki M; Wang R; Jun HS; Pittenger GL; Taylor-Fishwick D; Vinik AI
    Ann Surg; 2004 Nov; 240(5):875-84. PubMed ID: 15492571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes.
    Kolb H; Oschilewski M; Oschilewski U; Schwab E; Moumé CM; Greulich B; Burkart V; Zielasek J; Kiesel U
    Diabetes Res; 1987 Sep; 6(1):21-7. PubMed ID: 3319352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciamexon in the low dose streptozotocin induced diabetes of mice.
    Linn T; Volkmann A; Germann H; Woehrle M; Bretzel RG; Bicker U; Federlin K
    Diabetes Res; 1987 Nov; 6(3):113-7. PubMed ID: 3325216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of differential survival of syngeneic islets transplanted into hyperglycemic C57BL/6J versus C57BL/KsJ mice.
    Leiter EH
    Transplantation; 1987 Sep; 44(3):401-6. PubMed ID: 2957837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse.
    Campbell IL; Oxbrow L; Koulmanda M; Harrison LC
    J Immunol; 1988 Feb; 140(4):1111-6. PubMed ID: 2963859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
    Herold KC; Bloch TN; Vezys V; Sun Q
    Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
    Rydgren T; Sandler S
    Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.